These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16260134)

  • 1. Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].
    Bennett F; Saksena AK; Lovey RG; Liu YT; Patel NM; Pinto P; Pike R; Jao E; Girijavallabhan VM; Ganguly AK; Loebenberg D; Wang H; Cacciapuoti A; Moss E; Menzel F; Hare RS; Nomeir A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):186-90. PubMed ID: 16260134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
    Aher NG; Pore VS; Mishra NN; Kumar A; Shukla PK; Sharma A; Bhat MK
    Bioorg Med Chem Lett; 2009 Feb; 19(3):759-63. PubMed ID: 19110424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048).
    Nomeir AA; Pramanik BN; Heimark L; Bennett F; Veals J; Bartner P; Hilbert M; Saksena A; McNamara P; Girijavallabhan V; Ganguly AK; Lovey R; Pike R; Wang H; Liu YT; Kumari P; Korfmacher W; Lin CC; Cacciapuoti A; Loebenberg D; Hare R; Miller G; Pickett C
    J Mass Spectrom; 2008 Apr; 43(4):509-17. PubMed ID: 18059003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
    Bartroli J; Turmo E; Algueró M; Boncompte E; Vericat ML; Conte L; Ramis J; Merlos M; García-Rafanell J; Forn J
    J Med Chem; 1998 May; 41(11):1869-82. PubMed ID: 9599237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
    Odds FC
    Curr Opin Investig Drugs; 2006 Aug; 7(8):766-72. PubMed ID: 16955689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic and clinical evaluation of posaconazole.
    Moore JN; Healy JR; Kraft WK
    Expert Rev Clin Pharmacol; 2015 May; 8(3):321-34. PubMed ID: 25916666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
    Ohwada J; Tsukazaki M; Hayase T; Oikawa N; Isshiki Y; Fukuda H; Mizuguchi E; Sakaitani M; Shiratori Y; Yamazaki T; Ichihara S; Umeda I; Shimma N
    Bioorg Med Chem Lett; 2003 Jan; 13(2):191-6. PubMed ID: 12482421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
    Nagappan V; Deresinski S
    Clin Infect Dis; 2007 Dec; 45(12):1610-7. PubMed ID: 18190324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists.
    Shah U; Lankin CM; Boyle CD; Chackalamannil S; Greenlee WJ; Neustadt BR; Cohen-Williams ME; Higgins GA; Ng K; Varty GB; Zhang H; Lachowicz JE
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4204-9. PubMed ID: 18558486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
    Shah U; Boyle CD; Chackalamannil S; Neustadt BR; Lindo N; Greenlee WJ; Foster C; Arik L; Zhai Y; Ng K; Wang S; Monopoli A; Lachowicz JE
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4199-203. PubMed ID: 18562199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
    Groll AH; Walsh TJ
    Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
    Cao X; Sun Z; Cao Y; Wang R; Cai T; Chu W; Hu W; Yang Y
    J Med Chem; 2014 May; 57(9):3687-706. PubMed ID: 24564525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.
    Lebouvier N; Pagniez F; Duflos M; Le Pape P; Na YM; Le Baut G; Le Borgne M
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3686-9. PubMed ID: 17482460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The latest data on posaconazole].
    Paugam A
    Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304.
    Loebenberg D; Cacciapuoti A; Parmegiani R; Moss EL; Menzel F; Antonacci B; Norris C; Yarosh-Tomaine T; Hare RS; Miller GH
    Antimicrob Agents Chemother; 1992 Feb; 36(2):498-501. PubMed ID: 1605621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Groll AH; Walsh TJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14 alpha-demethylase (CYP51).
    Zhao QJ; Hu HG; Li YW; Song Y; Cai LZ; Wu QY; Jiang YY
    Chem Biodivers; 2007 Jul; 4(7):1472-9. PubMed ID: 17638327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel triazole antifungal derivatives by structure-based bioisosterism.
    Sheng C; Che X; Wang W; Wang S; Cao Y; Miao Z; Yao J; Zhang W
    Eur J Med Chem; 2011 Nov; 46(11):5276-82. PubMed ID: 21983332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.
    Hof H
    Mycoses; 2006; 49 Suppl 1():2-6. PubMed ID: 16961575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.